Financials BIO-UV Group

Equities

ALTUV

FR0013345493

Electrical Components & Equipment

Market Closed - Euronext Paris 11:35:01 2024-07-05 am EDT 5-day change 1st Jan Change
2.18 EUR -0.91% Intraday chart for BIO-UV Group -1.80% -10.84%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 24.92 27.43 69.53 52.95 47.1 24.75
Enterprise Value (EV) 1 25.66 38.77 70.62 73.11 74.27 50.3
P/E ratio 538 x -61.2 x 98.6 x 78.6 x 19.6 x 199 x
Yield - - - - 0.84% -
Capitalization / Revenue 1.9 x 1.32 x 2.11 x 1.54 x 0.92 x 0.59 x
EV / Revenue 1.96 x 1.86 x 2.14 x 2.12 x 1.45 x 1.19 x
EV / EBITDA 103 x -626 x 41.3 x 53 x 16.2 x 19.5 x
EV / FCF -6.19 x -9.81 x -19 x 15.4 x -8.36 x 11 x
FCF Yield -16.2% -10.2% -5.27% 6.5% -12% 9.08%
Price to Book 1.49 x 1.71 x 2.27 x 1.74 x 1.46 x 0.77 x
Nbr of stocks (in thousands) 7,838 7,838 10,347 10,105 10,097 10,125
Reference price 2 3.180 3.500 6.720 5.240 4.665 2.445
Announcement Date 4/30/19 5/5/20 5/3/21 4/29/22 4/4/23 4/30/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 13.1 20.82 32.97 34.49 51.29 42.12
EBITDA 1 0.2493 -0.0619 1.712 1.38 4.575 2.586
EBIT 1 0.0148 -0.3498 1.399 0.9976 4.132 2.298
Operating Margin 0.11% -1.68% 4.24% 2.89% 8.06% 5.46%
Earnings before Tax (EBT) 1 -0.197 -0.777 0.5535 0.6313 2.995 0.0155
Net income 1 0.0463 -0.4481 0.5839 0.6894 2.418 0.1249
Net margin 0.35% -2.15% 1.77% 2% 4.71% 0.3%
EPS 2 0.005908 -0.0572 0.0681 0.0666 0.2380 0.0123
Free Cash Flow 1 -4.146 -3.951 -3.723 4.753 -8.888 4.567
FCF margin -31.65% -18.98% -11.29% 13.78% -17.33% 10.84%
FCF Conversion (EBITDA) - - - 344.49% - 176.61%
FCF Conversion (Net income) - - - 689.43% - 3,656.64%
Dividend per Share - - - - 0.0390 -
Announcement Date 4/30/19 5/5/20 5/3/21 4/29/22 4/4/23 4/30/24
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.73 11.3 1.09 20.2 27.2 25.5
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.941 x -183 x 0.6342 x 14.61 x 5.939 x 9.878 x
Free Cash Flow 1 -4.15 -3.95 -3.72 4.75 -8.89 4.57
ROE (net income / shareholders' equity) 0.41% -2.74% 2.53% 2.27% 7.67% 0.39%
ROA (Net income/ Total Assets) 0.04% -0.68% 1.98% 0.94% 3.33% 1.97%
Assets 1 116.4 66.3 29.44 73.55 72.67 6.325
Book Value Per Share 2 2.140 2.040 2.960 3.020 3.190 3.170
Cash Flow per Share 2 0.1100 0.1500 1.230 1.010 0.2000 0.2700
Capex 1 1.97 1.91 3.02 2.73 2.22 1.96
Capex / Sales 15.04% 9.17% 9.15% 7.91% 4.33% 4.66%
Announcement Date 4/30/19 5/5/20 5/3/21 4/29/22 4/4/23 4/30/24
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALTUV Stock
  4. Financials BIO-UV Group